NEW YORK (GenomeWeb News) – The genomics research services company BioServe will provide clinical biosample and other services to the Fairbanks Institute for Healthy Communities as part of its Indiana-based study of type 2 diabetes.

BioServe said today that it will support the Fairbanks Institute's contributions to the Indiana Health Study, which is a community-based initiative aimed at using the population of central Indiana in creating a research platform that will lead to the development of new diagnostics and drugs for diseases such as heart disease, cancer, and diabetes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.